Table 4.
Protein identification from the third set of experiments: concentrated AF
Iso-electric point | Retention time | Protein identification | Protein name | Identification Method |
---|---|---|---|---|
Protein ID from fractions with over expression in group 1 (Preterm Labor – Term delivery) | ||||
4.3 – 4.6 | 12.0 – 13.0 | P08833 | Insulin-like growth factor binding protein 1 precursor (Placental protein 12) | MALDI-TOF/MS |
4.3 – 4.6 | 13.0 – 14.1 | Q8TCG4 | TPMsk1 (Tropomyosin sk1 fragment) | MALDI-TOF/MS |
4.6 – 4.9 | 13.7 – 14.3 | P31025 | Von Ebner's gland protein precursor (Tear lipocalin) | MALDI-TOF/MS, Nanospray-ESI-IT |
4.3 – 4.6 | 12.0 – 13.0 | P13232 | Interleukin-7 precursor | Nanospray-ESI-IT |
4.9 – 5.2 | 13.7 – 14.3 | P02760 | AMBP (Alpha-1-microglobulin/bikunin precursor) | MALDI-TOF/MS |
5.2 – 5.5 | 13.9 – 14.3 | P51812 | Ribosomal protein S6 kinase alpha 3 | MALDI-TOF/MS |
5.5 – 5.8 | 15.8 – 16.4 | P02647 | Apolipoprotein A1 | MALDI-TOF/MS, Nanospray-ESI-IT |
Protein ID from fractions with over expression in group 3 (Preterm Labor – Preterm delivery – Intra-amniotic infection/inflammation) | ||||
5.5 – 5.8 | 8.8 – 9.9 | 098237 | MHC class I chain-related protein A (Fragment) | MALDI-TOF/MS |
5.5 – 5.8 | 8.8 – 9.9 | Q8TD37 | Transcription elongation factor A Protein 2 | MALDI-TOF/MS |
5.5 – 5.8 | 8.8 – 9.9 | Q8N1D9 | SRY (Sex determining region Y)-box 5 | MALDI-TOF/MS |
5.5 – 5.8 | 12.2 – 12.8 | Q92657 | HP8 (Human peptide 8) | MALDI-TOF/MS |
5.5 – 5.8 | 12.8 – 13.7 | 095456 | Down Syndrome Critical Region Protein 2 | Nanospray-ESI-IT |